Skip to main content
Home

Breadcrumb

  1. Home
  2. News
  3. Search results
Displaying results 126 - 150 of 306 Clear search
Wellcome Sanger Institute
24 Sep 2020

Ambitious genomics project to understand how aquatic species thrive together

The genetic codes of 1,000 aquatic species – representing 500 symbiotic partnerships – will be sequenced by the Wellcome Sanger Institute and its collaborators, in a mission to understand how these organisms have changed to depend on each other for survival.

Wellcome Sanger Institute
22 Sep 2020

Key discovery in psoriatic arthritis points way for developing targeted treatments

A new study has revealed psoriatic arthritis may be activated by the same trigger in different patients. Researchers from the University of Oxford and the Wellcome Sanger Institute identified high levels of a specific receptor in immune cells from psoriatic arthritis patients, giving the strongest evidence yet of a single cause for the disease.

Wellcome Sanger Institute
18 Sep 2020

Future of genomic research at risk without greater public trust in how genetic data is shared

The largest ever survey on global public attitudes towards genomic research and data sharing suggests that work is needed to raise levels of public trust in how genetic data is used in order for that data to fulfil its promise to advance human health and medicine.

Wellcome Sanger Institute
04 Sep 2020

Genetic information can predict predisposition to rare and common blood diseases

Two large-scale genetic studies have identified the bulk of genetic variation that influences medically-important characteristics of our blood cells.

Wellcome Sanger Institute
28 Aug 2020

Mosquito immune system mapped to help fight malaria

Scientists have created the first cell atlas of mosquito immune cells, to understand how mosquitoes fight malaria and other infections. Researchers from the Wellcome Sanger Institute, Umeå University, Sweden and the National Institutes of Health (NIH), USA, discovered new types of mosquito immune cells, including a rare cell type that could be involved in limiting malaria infection. They also…

Wellcome Sanger Institute
21 Aug 2020

Genomics biotech pioneer, Global Gene Corp wins $1m "Star Trek" Roddenberry Prize

The Roddenberry Foundation today announced the winners of its $1 million biennial prize—designed to advance the vision of Star Trek creator Gene Roddenberry—to four organizations working to better humanity amidst the challenges of the global pandemic.

Wellcome Sanger Institute
12 Aug 2020

New podcast provides digital mentoring tips for early career researchers

A new podcast has been launched to bring digital mentoring and career development advice to early career researchers in the life sciences. The ‘Your Digital Mentor’ podcast aims to kickstart the conversation around mentoring and other aspects of research culture, with a special focus on low and middle-income countries (LMIC).

Wellcome Sanger Institute
31 Jul 2020

New drug targets for lethal brain cancer discovered

Researchers have engineered a new mouse model for studying glioblastoma, the most aggressive type of brain cancer.

Wellcome Sanger Institute
30 Jul 2020

Steroids help tumours suppress immune system, offering new immunotherapy targets

A study has revealed that tumours can evade the immune system by telling immune cells to produce immunosuppressive steroids. Researchers from the Wellcome Sanger Institute, Department of Pathology, University of Cambridge, and MRC Cancer Unit, discovered that immune T cells from mouse skin and breast tumours secrete steroids, and that preventing this steroid production reduced growth of tumours…

Wellcome Sanger Institute
27 Jul 2020

Free online public talks celebrate 20th anniversary of the Human Genome Project

The Wellcome Genome Campus is launching a series of free monthly ‘Genome Lates’, on-line public talks to celebrate 20 years since the landmark first draft of the complete human genome was produced.

Wellcome Sanger Institute
14 Jul 2020

Explore Covid-19 science in action with new Human Cell Atlas animation

A new animation has been created for secondary school students to explore how the SARS-CoV-2 coronavirus responsible for COVID-19 works, and how the Human Cell Atlas (HCA) consortium is mapping how the virus interacts with the human body.

Wellcome Sanger Institute
09 Jul 2020

Launch of virtual Sanger seminar series

The Wellcome Sanger Institute is pleased to launch a new series of virtual seminars, showcasing the diversity of genomic research at the Institute aimed at tackling some of the biggest challenges in human health and disease. From mapping all cell types in the human body, to understanding the evolution of cancer and life on Earth, senior scientists and faculty at the Sanger Institute will present…

Wellcome Sanger Institute
09 Jul 2020

Drug screens and CRISPR combine to help make better cancer drugs

Improved understanding of the biological mechanisms underpinning drug response will enable faster, more efficient drug development.

Wellcome Sanger Institute
19 Jun 2020

Update to DECIPHER brings power to clinical genomics

Update to rare disease database allows researchers and clinicians to input, interpret and share all types of genomic variants in all regions of the genome.

Wellcome Sanger Institute
17 Jun 2020

Keen to return to a scientific career? Applications are open for the Janet Thornton Fellowship

Have you had a career break from science, and would like to return? The Wellcome Sanger Institute has created a postdoctoral fellowship specifically for people who have been out of scientific research for 12 months or more.

Wellcome Sanger Institute
12 Jun 2020

Sanger researcher wins prize from European Society for Human Genetics

Dr Gosia Trynka, Group Leader at the Wellcome Sanger Institute, has been awarded the 2020 Leena Peltonen prize by the European Society for Human Genetics (ESHG). This prize is given every two years to an outstanding young researcher in the field of human genetics.

Wellcome Sanger Institute
29 May 2020

4,000 years of contact, conflict and cultural change had little genetic impact on Near East

The Near East was a crossroad for the ancient world’s greatest civilizations, and invasions over centuries caused enormous changes in cultures, religions and languages. However, a new study of the DNA of ancient skeletons spanning 4,000 years has revealed that most of these changes had no lasting effect on the genetics of the local population of Beirut. 

Wellcome Sanger Institute
26 May 2020

Analysis of COVID-19 Genomes reveals large numbers of introductions to the UK in March

Data reports published by the COVID-19 Genomics UK Consortium (COG-UK) show the value in mapping COVID-19 lineages across the UK to understand how the virus is spreading at national, regional and local levels.

Wellcome Sanger Institute
19 May 2020

Potentially cancerous cells kept in check by competitive neighbours, study of oesophagus finds

The expansion of ‘mutant’ cells that could lead to cancer is often kept in check by their neighbours, research from the Wellcome Sanger Institute, the University of Cambridge and their collaborators has found. The team discovered that when equally-matched cells in the oesophagus of mice coincided, they acted as a brake on one another’s growth.

Wellcome Sanger Institute
23 Apr 2020

Key nose cells identified as likely COVID-19 entry points

Study with Human Cell Atlas could help understand transmission of the virus.

Wellcome Sanger Institute
23 Apr 2020

Normal human uterus is colonised by clones with cancer-driving mutations that arise early in life, study finds

Many cells in the inner lining of the uterus carry ‘cancer-driving’ mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators. The research team conducted whole-genome sequencing of healthy human endometrium, providing a comprehensive overview of the rates and patterns of DNA changes in this tissue…

Wellcome Sanger Institute
16 Apr 2020

Experience matters for immune cells - discovery of T cells response spectrum could help understand immune diseases

The discovery that immune T cells have a spectrum of responsiveness could shed light on how our immune system responds to infections and cancer, and what goes wrong in immune diseases. Researchers at the Wellcome Sanger Institute, Open Targets, Biogen, GSK and their collaborators found that T cells responded very differently to immune signals the more 'training' they had been exposed to, rather…

Wellcome Sanger Institute
23 Mar 2020

UK launches whole genome sequence alliance to map spread of coronavirus

The Wellcome Sanger Institute will collaborate with expert groups across the country to analyse the genetic code of COVID-19 samples circulating in the UK, providing public health agencies with a unique tool to combat the virus.

Wellcome Sanger Institute
17 Mar 2020

New research on brain structure highlights cells linked to Alzheimer's and autism

New insights into the architecture of the brain have been revealed by scientists at the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute and their collaborators. The researchers discovered that cells in the cerebral cortex of mice, called astrocytes, are more diverse than previously thought, with distinct layers of astrocytes across the cerebral cortex that provide the…

Wellcome Sanger Institute
21 Feb 2020

Origins of immune system mapped, opening doors for new cancer immunotherapies

A first cell atlas of the human thymus gland could lead to new immune therapies to treat cancer and autoimmune diseases. Researchers from the Wellcome Sanger Institute, Newcastle University and Ghent University, Belgium, mapped thymus tissue through the human lifespan to understand how it develops and makes vital immune cells called T cells. In the future, this information could help researchers…

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • …
  • Next page ›
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS